Anaptysbio, IncANAB
Price (close)
$51.00
Market cap
$1.5B
P/E
7.7x
Revenue (TTM)
$237.6M
Net income
$195.7M
Dividend yield
—
1-year total return
247.1%
Net margin
82.4%
Revenue growth
92.9%
Debt / equity
—
What Anaptysbio, Inc does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $75.0M | $63.2M | $10.3M | $17.2M | $91.3M | $234.6M |
| Net income | -$19.9M | -$57.8M | -$128.7M | -$163.6M | -$145.2M | -$13.2M |
| Free cash flow | -$14.7M | -$47.3M | -$74.0M | -$121.6M | -$135.7M | $19.6M |
More on ANAB.
- Anaptysbio, Inc summary
- Anaptysbio, Inc financial statements
- Anaptysbio, Inc key metrics
- Anaptysbio, Inc health scores and style box
- Anaptysbio, Inc earnings
- Anaptysbio, Inc dividends
- Anaptysbio, Inc valuation
- Anaptysbio, Inc ownership and insiders
- Anaptysbio, Inc peers
Figures from Anaptysbio, Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.